Biofrontera Inc. Company Profile
NASDAQ: BFRIHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Biofrontera at a glance
Biofrontera Inc. (NASDAQ: BFRI) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector headquartered in Woburn, MA. Biofrontera is led by Dr. Hermann Luebbert Ph.D. and employs about 84 people. The company's shares have traded publicly since 2021.
At a market capitalization of $13.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001858685, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Biofrontera do?
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Biofrontera Inc.
- Ticker
- NASDAQ: BFRI
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Hermann Luebbert Ph.D.
- Employees
- 84
- Headquarters
- 660 Main Street, Woburn, MA, United States
- Phone
- 781 245 1325
- Website
- biofrontera-us.com
- IPO year
- 2021
- Market cap
- $13.89M
- SEC CIK
- 0001858685
Companies similar to Biofrontera
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CABRCaring Brands Inc. | 1.16 | -4.92% | $12.03M | vs BFRI |
| APUSApimeds Pharmaceuticals US Inc. | 5.51 | -21.84% | $8.32M | vs BFRI |
| INMInMed Pharmaceuticals Inc. | 1.33 | 0.00% | $7.31M | vs BFRI |
| UPCUniverse Pharmaceuticals Inc. Class A | 4.18 | -5.00% | $21.00M | vs BFRI |
| GELSGelteq Limited | 0.5488 | -1.98% | $5.88M | vs BFRI |
| SNOASonoma Pharmaceuticals Inc. | 1.16 | -4.92% | $5.55M | vs BFRI |
| AYTUAytu BioPharma Inc. | 2.05 | 0.00% | $22.28M | vs BFRI |
| RDHLRedhill Biopharma Ltd. ADR | 0.578 | +21.94% | $5.14M | vs BFRI |